Celonic AG-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Celonic AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014285
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Celonic AG (Celonic), a subsidiary of JRS Pharma LP is a biotechnology company that provides contract development manufacturing organization services. The company’s services include development of cell lines and biotechnological production processes, full GMP analytics, and manufacture of active pharmaceutical ingredients and product batches for clinical trials. Its SEFEX is a proprietary, royalty-free host system and a cell line development platform used for the generation of cell lines for new biological entities and biosimilar products. The company operates through its manufacturing facility located in France, Germany and Switzerland. Celonic is headquartered in Basel, Switzerland.

Celonic AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Celonic AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Celonic AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Celonic AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Celonic AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Celonic AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Celonic AG, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Celonic Acquires Bio-Manufacturing Facility from Glycotope 10
Partnerships 11
Heidelberg Pharma Enters into Agreement with Celonic 11
Istituto Biochimico Italiano Giovanni Lorenzini Enters into Agreement with Celonic 12
Protagen Protein Services, Assign International, Aurigon, Celonic and PharmaLex Form Joint Venture 13
Licensing Agreements 14
Trenzyme Enters into Licensing Agreement with Celonic 14
Asset Transactions 15
JRS Rettenmaier Acquires Contract Manufacturing Business Of Celonic 15
Acquisition 16
JRS Rettenmaier Acquires Celonic’s German Arm 16
Celonic AG – Key Competitors 17
Celonic AG – Key Employees 18
Celonic AG – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 19
Recent Developments 20
Strategy And Business Planning 20
Sep 13, 2017: Merck Expands Celonic’s Upstream Capabilities with Mobius Single-use Bioreactors 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Celonic AG, Pharmaceuticals & Healthcare, Key Facts 2
Celonic AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Celonic AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Celonic AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Celonic AG, Deals By Therapy Area, 2011 to YTD 2017 8
Celonic AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Celonic Acquires Bio-Manufacturing Facility from Glycotope 10
Heidelberg Pharma Enters into Agreement with Celonic 11
Istituto Biochimico Italiano Giovanni Lorenzini Enters into Agreement with Celonic 12
Protagen Protein Services, Assign International, Aurigon, Celonic and PharmaLex Form Joint Venture 13
Trenzyme Enters into Licensing Agreement with Celonic 14
JRS Rettenmaier Acquires Contract Manufacturing Business Of Celonic 15
JRS Rettenmaier Acquires Celonic's German Arm 16
Celonic AG, Key Competitors 17
Celonic AG, Key Employees 18
Celonic AG, Joint Venture 19

★海外企業調査レポート[Celonic AG-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Proteus Digital Health Inc:企業の戦略的SWOT分析
    Proteus Digital Health Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Amur Minerals Corporation:企業の戦略・SWOT・財務分析
    Amur Minerals Corporation - Strategy, SWOT and Corporate Finance Report Summary Amur Minerals Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • FOCUS Brands Inc.:企業の戦略・SWOT・財務情報
    FOCUS Brands Inc. - Strategy, SWOT and Corporate Finance Report Summary FOCUS Brands Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Robert Half International Inc. (RHI):企業の財務・戦略的SWOT分析
    Robert Half International Inc. (RHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • The Midcounties Co-operative:企業の戦略・SWOT・財務情報
    The Midcounties Co-operative - Strategy, SWOT and Corporate Finance Report Summary The Midcounties Co-operative - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • HeartWare International Inc:企業の戦略的SWOT分析
    HeartWare International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Celgene Corporation:企業の戦略・SWOT・財務情報
    Celgene Corporation - Strategy, SWOT and Corporate Finance Report Summary Celgene Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Atlas Copco AB (ATCO A):企業の財務・戦略的SWOT分析
    Atlas Copco AB (ATCO A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Toyo Engineering & Construction Sdn Bhd:企業の戦略的SWOT分析
    Toyo Engineering & Construction Sdn Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Telecom Egypt Company:戦略・SWOT・企業財務分析
    Telecom Egypt Company - Strategy, SWOT and Corporate Finance Report Summary Telecom Egypt Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Takeda Pharmaceuticals International AG-製薬・医療分野:企業M&A・提携分析
    Summary Takeda Pharmaceuticals International AG (Takeda), a subsidiary of Takeda Pharmaceutical Company Ltd is a developer, manufacturer and distributor of pharmaceutical products. The company offers treatments in respiratory and immunology, central nervous system, cardiovascular and metabolic, canc …
  • Hunan Fangsheng Pharmaceutical Co Ltd (603998):製薬・医療:M&Aディール及び事業提携情報
    Summary Hunan Fangsheng Pharmaceutical Co Ltd (Fangsheng Pharma) is a research-based comprehensive pharmaceutical enterprise offers research, development, manufacturing and sales of pharmaceuticals. The enterprise’ products include tablets, capsules, granules, oral suspension, powder, suppository, p …
  • Sacmi Imola S.C. :企業の戦略・SWOT・財務情報
    Sacmi Imola S.C. - Strategy, SWOT and Corporate Finance Report Summary Sacmi Imola S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Hemostemix Inc (HEM):製薬・医療:M&Aディール及び事業提携情報
    Summary Hemostemix Inc (Hemostemix), formerly Theravitae Inc, is a biotechnology company that develops, manufactures and commercializes proprietary autologous cell therapy for the treatment of ischemic diseases. The company’s clinical-stage candidate includes ACP-01, an autologous cell therapy for t …
  • Tong Yang Life Insurance Co., Ltd.:企業の戦略・SWOT・財務分析
    Tong Yang Life Insurance Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tong Yang Life Insurance Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • BHI Co Ltd (083650):企業の財務・戦略的SWOT分析
    BHI Co Ltd (083650) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • West Japan Railway Co (9021):企業の財務・戦略的SWOT分析
    West Japan Railway Co (9021) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Fujitsu Australia Ltd:企業の戦略的SWOT分析
    Fujitsu Australia Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • SBM Offshore NV (SBMO):企業の財務・戦略的SWOT分析
    SBM Offshore NV (SBMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Syniverse Holdings Inc:企業の戦略的SWOT分析
    Syniverse Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆